Stereocontrolled synthesis of lissoclinolide (cas 132074-82-9) by sequential transition metal-catalyzed lactonization/cross-coupling reactions
-
Add time:07/29/2019 Source:sciencedirect.com
lissoclinolide (cas 132074-82-9), 1, which is an antibiotic butenolide isolated from a Tuncate, has been synthesized stereoselectively by a reaction sequence in which the Ag(I)-catalyzed lactonization of (2E,6E)-2-bromo-8-hydroxy-2,6-octadien-4-ynoic acid, (E,E)-13, and the Pd/Cu-catalyzed cross-coupling reaction of so obtained (Z)-2-bromo-5-[(E)-4-hydroxy-2-butenylidene]-5H-furan-2-one, (Z,E)-14, with (E)-3-hydroxy-1-propenyltributylstannane, 15, have been used as the key steps.
We also recommend Trading Suppliers and Manufacturers of lissoclinolide (cas 132074-82-9). Pls Click Website Link as below: cas 132074-82-9 suppliers
Prev:A profile of the in vitro antitumor activity of lissoclinolide (cas 132074-82-9)
Next:A highly efficient and selective synthesis of lissoclinolide (cas 132074-82-9) featuring hydrogen transfer hydrozirconation,trans-selective Pd-catalyzed cross coupling of alkenylzirconiums with 1,1-dibromoalkenes and Ag-catalyzed lactonization providing(Z)-γ-alkylidenebutenolides) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A highly efficient and selective synthesis of lissoclinolide (cas 132074-82-9) featuring hydrogen transfer hydrozirconation,trans-selective Pd-catalyzed cross coupling of alkenylzirconiums with 1,1-dibromoalkenes and Ag-catalyzed lactonization providing(Z)-γ-alkylidenebutenolides07/30/2019
- A profile of the in vitro antitumor activity of lissoclinolide (cas 132074-82-9)07/28/2019


